Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Study of the Effects of Dopaminergic Medications on Dopamine Transporter Imaging in Parkinson's Disease

This study has been completed.
Sponsor:
Collaborators:
Boehringer Ingelheim
Information provided by:
Institute for Neurodegenerative Disorders
ClinicalTrials.gov Identifier:
NCT00096720
First received: November 12, 2004
Last updated: September 28, 2010
Last verified: May 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2007
  Estimated Primary Completion Date: No date given